A detailed history of Meyer Handelman CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Meyer Handelman CO holds 34,608 shares of EW stock, worth $2.57 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
34,608
Previous 39,108 11.51%
Holding current value
$2.57 Million
Previous $3.61 Million 36.79%
% of portfolio
0.08%
Previous 0.13%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$59.7 - $93.78 $268,650 - $422,010
-4,500 Reduced 11.51%
34,608 $2.28 Million
Q1 2024

Apr 11, 2024

BUY
$72.54 - $95.56 $288,128 - $379,564
3,972 Added 11.3%
39,108 $3.74 Million
Q4 2023

Jan 17, 2024

SELL
$61.71 - $77.76 $277,695 - $349,920
-4,500 Reduced 11.35%
35,136 $2.68 Million
Q3 2023

Nov 06, 2023

BUY
$69.28 - $93.38 $644,304 - $868,434
9,300 Added 30.66%
39,636 $2.75 Million
Q2 2023

Jul 21, 2023

BUY
$81.41 - $94.33 $521,675 - $604,466
6,408 Added 26.78%
30,336 $2.86 Million
Q1 2023

Apr 11, 2023

SELL
$74.26 - $84.51 $475,858 - $541,540
-6,408 Reduced 21.12%
23,928 $1.98 Million
Q4 2021

Jan 25, 2022

BUY
$106.37 - $130.68 $630,561 - $774,671
5,928 Added 24.29%
30,336 $3.93 Million
Q1 2021

May 03, 2021

BUY
$78.68 - $90.67 $504,181 - $581,013
6,408 Added 35.6%
24,408 $2.04 Million
Q4 2020

Feb 03, 2021

BUY
$71.69 - $91.23 $344,112 - $437,904
4,800 Added 36.36%
18,000 $1.64 Million
Q2 2020

Jul 16, 2020

BUY
$57.54 - $76.95 $506,352 - $677,160
8,800 Added 200.0%
13,200 $912,000
Q3 2017

Oct 25, 2017

BUY
$36.29 - $38.83 $159,676 - $170,852
4,400
4,400 $481,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Meyer Handelman CO Portfolio

Follow Meyer Handelman CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meyer Handelman CO, based on Form 13F filings with the SEC.

News

Stay updated on Meyer Handelman CO with notifications on news.